Maziar Lalezary

646 total citations
15 papers, 398 citations indexed

About

Maziar Lalezary is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Maziar Lalezary has authored 15 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 11 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Infectious Diseases. Recurrent topics in Maziar Lalezary's work include Retinal Diseases and Treatments (9 papers), Retinal Imaging and Analysis (7 papers) and Glaucoma and retinal disorders (7 papers). Maziar Lalezary is often cited by papers focused on Retinal Diseases and Treatments (9 papers), Retinal Imaging and Analysis (7 papers) and Glaucoma and retinal disorders (7 papers). Maziar Lalezary collaborates with scholars based in United States. Maziar Lalezary's co-authors include Edward Cherney, Stephen J. Kim, Scott D. Schoenberger, Pamela A. Sample, Linda M. Zangwill, Robert N. Weinreb, Jinsong Sheng, Kasra A. Rezaei, Ali Tafreshi and Christopher Bowd and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Maziar Lalezary

15 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maziar Lalezary United States 9 357 239 68 20 20 15 398
Guangxian Tang China 9 239 0.7× 164 0.7× 68 1.0× 15 0.8× 8 0.4× 27 299
A. Lleó-Pérez Spain 12 334 0.9× 242 1.0× 73 1.1× 14 0.7× 14 0.7× 29 413
Maribel López-Gálvez Spain 5 382 1.1× 296 1.2× 83 1.2× 23 1.1× 4 0.2× 8 434
Yoko Takatsuna Japan 11 305 0.9× 222 0.9× 62 0.9× 7 0.3× 9 0.5× 29 347
Anselm Juenemann Germany 7 288 0.8× 230 1.0× 112 1.6× 32 1.6× 7 0.3× 12 405
Nisha Kheradiya United States 7 285 0.8× 194 0.8× 37 0.5× 17 0.8× 4 0.2× 10 322
Ricardo Lamy United States 8 201 0.6× 184 0.8× 42 0.6× 14 0.7× 6 0.3× 19 295
Faisal A. Almobarak Saudi Arabia 13 709 2.0× 470 2.0× 84 1.2× 67 3.4× 17 0.8× 47 750
Lebriz Ersoy Germany 11 378 1.1× 225 0.9× 100 1.5× 6 0.3× 7 0.3× 26 460
Waseem M. Al-Zamil Saudi Arabia 7 305 0.9× 202 0.8× 128 1.9× 7 0.3× 6 0.3× 7 391

Countries citing papers authored by Maziar Lalezary

Since Specialization
Citations

This map shows the geographic impact of Maziar Lalezary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maziar Lalezary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maziar Lalezary more than expected).

Fields of papers citing papers by Maziar Lalezary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maziar Lalezary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maziar Lalezary. The network helps show where Maziar Lalezary may publish in the future.

Co-authorship network of co-authors of Maziar Lalezary

This figure shows the co-authorship network connecting the top 25 collaborators of Maziar Lalezary. A scholar is included among the top collaborators of Maziar Lalezary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maziar Lalezary. Maziar Lalezary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chan, Clement K., Wesley T. Beaulieu, Brandon J. Lujan, et al.. (2023). Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration. Translational Vision Science & Technology. 12(9). 1–1. 1 indexed citations
2.
Chan, Clement K., Maziar Lalezary, Prema Abraham, et al.. (2022). Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration in Vulnerable Fellow Eyes. Ophthalmology Retina. 6(6). 484–494. 12 indexed citations
3.
Chan, Clement K., David Sarraf, Prema Abraham, et al.. (2020). Meticulous multimodal analysis of aflibercept therapy for submacular vascularized pigment epithelial detachment associated with neovascular AMD in a prospective case series, the EVEN study. American Journal of Ophthalmology Case Reports. 20. 100916–100916. 5 indexed citations
4.
Patel, Shriji, Stephen J. Kim, Maziar Lalezary, et al.. (2019). Three-Year Findings on Intraocular Pressure Changes in The Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study. Ophthalmic surgery, lasers & imaging retina. 50(6). 371–376. 1 indexed citations
5.
Lalezary, Maziar, Steven Lin, Clement K. Chan, et al.. (2017). Prophylactic Ranibizumab for Exudative age-related macular degeneration (AMD) in Vulnerable Eyes with Non-Exudative AMD Trial (PREVENT): A prospective controlled clinical trial. Investigative Ophthalmology & Visual Science. 58(8). 410–410. 2 indexed citations
6.
Chen, Xuejing, Mayss Al‐Sheikh, Clement K. Chan, et al.. (2016). TYPE 1 VERSUS TYPE 3 NEOVASCULARIZATION IN PIGMENT EPITHELIAL DETACHMENTS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. Retina. 36(Supplement 1). S50–S64. 31 indexed citations
7.
Lalezary, Maziar. (2015). VANISHING RETINAL DETACHMENT. Retinal Cases & Brief Reports. 9(4). 320–322. 1 indexed citations
8.
Lalezary, Maziar, Rohan J. Shah, Rahul K. Reddy, et al.. (2014). Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study. Ophthalmology. 121(10). 1983–1989. 28 indexed citations
9.
Kim, Stephen, Rahul Reddy, Maziar Lalezary, et al.. (2013). Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) study: findings at 3 months. Clinical ophthalmology. 7. 1761–1761. 15 indexed citations
10.
Lalezary, Maziar, Scott D. Schoenberger, Edward Cherney, & Anita Agarwal. (2012). ACUTE MACULAR NEURORETINOPATHY. Retinal Cases & Brief Reports. 7(1). 5–8. 5 indexed citations
11.
Schoenberger, Scott D., Stephen J. Kim, Jinsong Sheng, et al.. (2012). Increased Prostaglandin E2 (PGE2) Levels in Proliferative Diabetic Retinopathy, and Correlation with VEGF and Inflammatory Cytokines. Investigative Ophthalmology & Visual Science. 53(9). 5906–5906. 116 indexed citations
12.
Jiramongkolchai, Kim, et al.. (2010). Influence of previous vitrectomy on incidence of macular oedema after cataract surgery in diabetic eyes. British Journal of Ophthalmology. 95(4). 524–529. 9 indexed citations
13.
Tafreshi, Ali, Pamela A. Sample, Jeffrey M. Liebmann, et al.. (2009). Visual Function-Specific Perimetry to Identify Glaucomatous Visual Loss Using Three Different Definitions of Visual Field Abnormality. Investigative Ophthalmology & Visual Science. 50(3). 1234–1234. 27 indexed citations
14.
Kwong, Jacky M. K., Maziar Lalezary, Christine Yang, et al.. (2006). Co-expression of heat shock transcription factors 1 and 2 in rat retinal ganglion cells. Neuroscience Letters. 405(3). 191–195. 17 indexed citations
15.
Lalezary, Maziar, Felipe A. Medeiros, Robert N. Weinreb, et al.. (2006). Baseline Optical Coherence Tomography Predicts the Development of Glaucomatous Change in Glaucoma Suspects. American Journal of Ophthalmology. 142(4). 576–582.e1. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guangxian Tang Breakdown of academic impact, for papers by A. Lleó-Pérez Breakdown of academic impact, for papers by Maribel López-Gálvez Breakdown of academic impact, for papers by Yoko Takatsuna Breakdown of academic impact, for papers by Anselm Juenemann Breakdown of academic impact, for papers by Nisha Kheradiya Breakdown of academic impact, for papers by Ricardo Lamy Breakdown of academic impact, for papers by Faisal A. Almobarak Breakdown of academic impact, for papers by Lebriz Ersoy Breakdown of academic impact, for papers by Waseem M. Al-Zamil
Rankless by CCL
2026